ZYME Competitors & Alternatives
Compare Zymeworks Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZYME
Main Stock$24.35
Tradestie Score
55
Market Cap
$1.28B
Revenue Growth
-0.9%
Analyst Upside
+64.9%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.35
|
$1.92B | - | 56 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$88.95
|
$1.92B | - | 47 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$55.69
|
$1.90B | 324.2 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.27
|
$1.84B | - | 52 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.65
|
$1.81B | - | 60 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.72
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.99
|
$1.78B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.35
|
$1.74B | - | 53 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.77
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$3.36
|
$1.65B | - | 58 | Compare |
More ZYME Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry